Absence of CALR mutations in JAK2 -negative polycythemia
Aurélie Chauveau, Olivier Nibourel, Sylvie Tondeur, Damien Luque Paz, Olivier Mansier, Franciane Paul, Mathieu Wémeau, Claude Preudhomme, Éric Lippert, Valérie Ugo
Abstract
Aurélie Chauveau, Olivier Nibourel, Sylvie Tondeur, Damien Luque Paz, Olivier Mansier, Franciane Paul, Mathieu Wémeau, Claude Preudhomme, Éric Lippert, Valérie Ugo
Abstract
Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) responsible for increased hematopoiesis, mainly affecting the erythroid lineage. The diagnosis of PV has been simplified enormously by the description of JAK2 mutations, affecting the canonical V617 in exon 14 in more than 95% of cases,
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) responsible for increased hematopoiesis, mainly affecting the erythroid lineage. The diagnosis of PV has been simplified enormously by the description of JAK2 mutations, affecting the canonical V617 in exon 14 in more than 95% of cases,
Key concepts: Polycythemia vera, Myeloproliferative neoplasm, Myelofibrosis, Mutation, Exon, Myeloproliferative Disorders, Haematopoiesis, Lineage (genetic)